Miller-The ASAM Principles of Addiction Medicine, 7e

Contents

15 The Pharmacology of Caffeine 217 Laura M. Juliano, Sergi Ferré, Darian Weaver, and Roland R. Griffiths 16 The Pharmacology of Nicotine and Tobacco 230 John A. Dani, Thomas R. Kosten, and Neal L. Benowitz 17 The Pharmacology of Cannabinoids 248 Justin Matheson, Katrina Mark, Daniele Piomelli, David A. Gorelick, and Bernard Le Foll 18 The Pharmacology of Hallucinogens 269 David B. Yaden, David S. Mathai, Michael P. Bogenschutz, and David E. Nichols

Section Editors iv Contributors vi Preface xxiii Acknowledgments xxv Tributes xxvi

SECTION 1 BASIC SCIENCE AND CORE CONCEPTS 1 1 Substance Use Disorders: The Neurobiology of Motivation Gone Awry 2 Nora D. Volkow, George F. Koob, and Ruben Baler 2 Recommended Use of Terminology in Addiction Medicine 27 Shannon C. Miller, Richard N. Rosenthal, Jeanette M. Tetrault, Sarah E. Wakeman, Andrew J. Saxon, and Sharon Levy 3 The Anatomy of Addiction 34 Michael J. Wesley, Colleen A. Hanlon, and Thomas J. R. Beveridge 4 Clinical Trials in Substance-Using Populations 48 Frank Vocci 5 Addiction Medicine Physicians and Collaborative Care Clinicians as Change Agents for Prevention and Public Health 64 Warren Yamashita, Kevin Kunz, and Omari Hodge 6 Climate Change and Addiction Medicine 76 Shannon C. Miller and John W. Sullenbarger 7 The Cigarette Industry’s Role in Promoting Tobacco Use Disorder 89 K. Michael Cummings 8 The Impact of the Alcohol Industry on Alcohol Use Disorder 105 Thomas F. Babor 9 The Impact of the Cannabis Industry on Cannabis Use Disorder 116 David H. Jernigan, Jih-Cheng Yeh, Connor Kubeisy, and Kevin A. Sabet SECTION 2 PHARMACOLOGY 128 10 Pharmacokinetic, Pharmacodynamic, and Pharmacogenomic Principles 129 Lori D. Karan, John G. McNutt, and Anne Zajicek 11 The Pharmacology of Alcohol 148 John J. Woodward 12 The Pharmacology of Nonalcohol Sedative Hypnotics 165 Carolina L. Haass-Koffler and Elinore F. McCance-Katz 13 The Pharmacology of Opioids 178 Daryl Shorter, Coreen B. Domingo, and Thomas R. Kosten 14 The Pharmacology of Stimulants 191 David A. Gorelick and Michael H. Baumann

19 The Pharmacology of Dissociatives 293 Nicholas Denomme, Hamilton Morris, Jason Wallach, and Shannon C. Miller 20 The Pharmacology of Inhalants 308 Robert L. Balster and Silvia L. Cruz 21 The Pharmacology of Anabolic-Androgenic Steroids 317 Scott E. Lukas 22 Electronic Drug Delivery Devices 337 Gideon St.Helen and Shannon C. Miller 23 Novel Psychoactive Substances 357 Kathryn Hawk, Barbara M. Kirrane, and Gail D’Onofrio

SECTION 3 EPIDEMIOLOGY AND PREVENTION 366 24 The Epidemiology of Substance Use Disorders 367 Silvia S. Martins, Megan E. Marziali, and Pia M. Mauro Sidebar Primary, Secondary, and Tertiary Prevention 385 James C. Anthony 25 Preventing Substance Use Among Children and Adolescents 390 Kenneth W. Griffin and Gilbert J. Botvin 26 Environmental Approaches to Prevention: Communities and Contexts 399 Mallie J. Paschall, Joel W. Grube, Robert F. Saltz, and Paul J. Gruenewald 27 Prevention of Prescription Medication Misuse 408 Beth Han, Christopher M. Jones, and Wilson M. Compton 28 The Harm Reduction Approach to Caring for People Who Use Substances 423 Alexander Y. Walley, Sharon Stancliff, and India Perez-Urbano 29 College Student Drinking 437 Lauren McClain, Frank J. Schwebel, Ursula Whiteside, Jason R. Kilmer, Ty W. Lostutter, and Mary E. Larimer 30 Policy and Leadership: Impact on Primary, Secondary, and Tertiary Prevention of Substance Use Disorders in Military Personnel and Beyond 453 Kenneth Hoffman and Janet H. Lenard Sidebar Challenges of Reintegration for Military Personnel

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.

and Their Families 464 Joan E. Zweben and Susan Storti

xxix